380 related articles for article (PubMed ID: 29457784)
1. HIV latency is reversed by ACSS2-driven histone crotonylation.
Jiang G; Nguyen D; Archin NM; Yukl SA; Méndez-Lagares G; Tang Y; Elsheikh MM; Thompson GR; Hartigan-O'Connor DJ; Margolis DM; Wong JK; Dandekar S
J Clin Invest; 2018 Mar; 128(3):1190-1198. PubMed ID: 29457784
[TBL] [Abstract][Full Text] [Related]
2. Cellular Gene Modulation of HIV-Infected CD4 T Cells in Response to Serial Treatment with the Histone Deacetylase Inhibitor Vorinostat.
Maxwell JW; Falcinelli SD; Nefedov A; Dorfmeier C; Wu G; Dewey M; Webber AL; Archin NM; Margolis DM; Hazuda DJ; Barnard RJO; Howell BJ
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295913
[TBL] [Abstract][Full Text] [Related]
3. H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells.
Tripathy MK; McManamy ME; Burch BD; Archin NM; Margolis DM
J Virol; 2015 Aug; 89(16):8392-405. PubMed ID: 26041287
[TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.
Lucera MB; Tilton CA; Mao H; Dobrowolski C; Tabler CO; Haqqani AA; Karn J; Tilton JC
J Virol; 2014 Sep; 88(18):10803-12. PubMed ID: 25008921
[TBL] [Abstract][Full Text] [Related]
5. X-Linked RNA-Binding Motif Protein Modulates HIV-1 Infection of CD4
Ma L; Jiang QA; Sun L; Yang X; Huang H; Jin X; Zhang C; Wang JH
mBio; 2020 Apr; 11(2):. PubMed ID: 32317327
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation.
Brogdon J; Ziani W; Wang X; Veazey RS; Xu H
Sci Rep; 2016 Dec; 6():39032. PubMed ID: 27941949
[TBL] [Abstract][Full Text] [Related]
7. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
8. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
[TBL] [Abstract][Full Text] [Related]
9. PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.
He Z; Jing S; Yang T; Chen J; Huang F; Zhang W; Peng Z; Liu B; Ma X; Wu L; Pan T; Zhang X; Li L; Cai W; Tang X; Zhang J; Zhang H
J Virol; 2020 May; 94(10):. PubMed ID: 32161174
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.
Friedman J; Cho WK; Chu CK; Keedy KS; Archin NM; Margolis DM; Karn J
J Virol; 2011 Sep; 85(17):9078-89. PubMed ID: 21715480
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor MC1293 induces latent HIV-1 reactivation by histone modification in vitro latency cell lines.
Qu X; Ying H; Wang X; Kong C; Zhou X; Wang P; Zhu H
Curr HIV Res; 2013 Jan; 11(1):24-9. PubMed ID: 23092175
[TBL] [Abstract][Full Text] [Related]
12. Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.
Nguyen K; Das B; Dobrowolski C; Karn J
mBio; 2017 Feb; 8(1):. PubMed ID: 28246360
[TBL] [Abstract][Full Text] [Related]
13. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors.
Archin NM; Keedy KS; Espeseth A; Dang H; Hazuda DJ; Margolis DM
AIDS; 2009 Sep; 23(14):1799-806. PubMed ID: 19590405
[TBL] [Abstract][Full Text] [Related]
14. HIV-Induced Epigenetic Alterations in Host Cells.
Abdel-Hameed EA; Ji H; Shata MT
Adv Exp Med Biol; 2016; 879():27-38. PubMed ID: 26659262
[TBL] [Abstract][Full Text] [Related]
15. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
Choudhary SK; Archin NM; Margolis DM
J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
[TBL] [Abstract][Full Text] [Related]
16. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
[TBL] [Abstract][Full Text] [Related]
17. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
[TBL] [Abstract][Full Text] [Related]
18. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.
Archin NM; Liberty AL; Kashuba AD; Choudhary SK; Kuruc JD; Crooks AM; Parker DC; Anderson EM; Kearney MF; Strain MC; Richman DD; Hudgens MG; Bosch RJ; Coffin JM; Eron JJ; Hazuda DJ; Margolis DM
Nature; 2012 Jul; 487(7408):482-5. PubMed ID: 22837004
[TBL] [Abstract][Full Text] [Related]
19. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
J Virol; 2018 May; 92(10):. PubMed ID: 29343578
[TBL] [Abstract][Full Text] [Related]
20. Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.
Victoriano AF; Imai K; Togami H; Ueno T; Asamitsu K; Suzuki T; Miyata N; Ochiai K; Okamoto T
FEBS Lett; 2011 Apr; 585(7):1103-11. PubMed ID: 21402072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]